IPCA LABORATORIES LTD#IPCALAB
Intraday stock for 30/05/2025
BUY
ENTRY:-1500
SL:-1475
TARGET:-1530
Disclaimer:-All views are my personal and only for educational purpose.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
29.05 INR
7.38 B INR
89.40 B INR
130.48 M
About IPCA LABORATORIES LTD
Sector
Industry
CEO
Pranay Godha
Website
Headquarters
Mumbai
Founded
1949
ISIN
INE571A01038
FIGI
BBG000D4LR21
Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.
Related stocks
IPCA LABORATORIES - RETEST OF SUPPORT BREAKDOWNSymbol - IPCALAB
Ipca Laboratories has recently experienced notable price movements, trading near resistance levels after a good pullback from lower levels. Currently, the stock is trading near major resistance zone, which follows a period of strong recovery from its earlier lows. However, the tren
The trend is strongIPCA CMP 1470
Elliott- thats an expanded flat corrective pattern on the right. The C wave is 1.618 of A. Hence to me the correction is over.
Fibs- the correction has halted at 50% from a higher swing. This is strength.
RSI- the oscillator has halted above the bull zone. Hence the trend is intact.
30th december ipca labs for intra cum swingipca labs has shown breakout on daily trendline
buy in zone 1638-1648
stoploss will be 1615
target will be 1670-1700-1720 ++
breakout is solid so you can add on dips to , it will rock in 2 to 4 days or today itself
PCA Laboratories LtdThe chart for IPCA Laboratories Ltd. (NSE) displays a potential flag pattern breakout, suggesting bullish momentum continuation. The price has broken out above the consolidation range, supported by a prior strong rally (flagpole) and notable volume activity. The RSI is near 62, indicating bullish mo
IPCA Lab Short IntradayIPCA is weak with volume. On critical price junction. We will wait for breakout for intraday shorts.
Trade Signal is 1503.4. Stock has taken support at this exact level multiple time.
Once break 1500 stock is weak and short trade get confirmation. We can keep target 1585-80
Once stock goes to 1
IPCA LABS - Shorts below 1550 you may think of buying a put option or selling futures if IPCA labs closes below 1550 levels and then you can thank me later by boosting, liking and sharing the post.
One of the first modern pharma factory of yesteryears was commissioned by Ipca at Mumbai in 1969. The company was originally promot
IPCALAB 1HRSWING TRADE
- EARN WITH ME DAILY 10K-20K –
IPCALAB Looking good for Downside..
When it break level 1558 and sustain.. it will go Downside...
SELL @ 1558
Target
1st 1548
2nd 1535
FNO
IPCALAB NOV FUT – LOT 6 (Qty-3900)
IPCALAB NOV 6200 PE – LOT 6 (Qty-3900) – PRICE (70.40)
Enjoy trading trade
IPCALAPEntry @1655 Above Close or retest range
Hold 1 month
Target 10% and 20%
SL day candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. risk ratio 1:1 to manage modified SL. This is not call, Just my idea. Pleas
IPCA Lab - Observing Buy SetupCMP 1361 on 09.08.24
The above weekly chart shows that the price has formed a cup & handle pattern in the last 2 years. If this pattern continues we can expect a breakout on the charts.
MACD is showing a likely crossover too.
Possible targets may be 1600/1800 or even more.
As long as it sustains abo
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IPCALAB is 1,439.70 INR — it has decreased by −0.76% in the past 24 hours. Watch IPCA LABORATORIES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange IPCA LABORATORIES LTD stocks are traded under the ticker IPCALAB.
IPCALAB stock has risen by 4.80% compared to the previous week, the month change is a 5.07% rise, over the last year IPCA LABORATORIES LTD has showed a 17.04% increase.
We've gathered analysts' opinions on IPCA LABORATORIES LTD future price: according to them, IPCALAB price has a max estimate of 1,810.00 INR and a min estimate of 1,320.00 INR. Watch IPCALAB chart and read a more detailed IPCA LABORATORIES LTD stock forecast: see what analysts think of IPCA LABORATORIES LTD and suggest that you do with its stocks.
IPCALAB reached its all-time high on Jan 7, 2025 with the price of 1,755.90 INR, and its all-time low was 2.75 INR and was reached on Sep 17, 2001. View more price dynamics on IPCALAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IPCALAB stock is 2.79% volatile and has beta coefficient of 0.59. Track IPCA LABORATORIES LTD stock price on the chart and check out the list of the most volatile stocks — is IPCA LABORATORIES LTD there?
Today IPCA LABORATORIES LTD has the market capitalization of 368.91 B, it has increased by 6.65% over the last week.
Yes, you can track IPCA LABORATORIES LTD financials in yearly and quarterly reports right on TradingView.
IPCA LABORATORIES LTD is going to release the next earnings report on Aug 19, 2025. Keep track of upcoming events with our Earnings Calendar.
IPCALAB earnings for the last quarter are 8.74 INR per share, whereas the estimation was 8.77 INR resulting in a −0.30% surprise. The estimated earnings for the next quarter are 8.85 INR per share. See more details about IPCA LABORATORIES LTD earnings.
IPCA LABORATORIES LTD revenue for the last quarter amounts to 22.47 B INR, despite the estimated figure of 22.30 B INR. In the next quarter, revenue is expected to reach 23.07 B INR.
IPCALAB net income for the last quarter is 678.20 M INR, while the quarter before that showed 2.48 B INR of net income which accounts for −72.67% change. Track more IPCA LABORATORIES LTD financial stats to get the full picture.
IPCA LABORATORIES LTD dividend yield was 0.27% in 2024, and payout ratio reached 13.76%. The year before the numbers were 0.32% and 18.54% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IPCA LABORATORIES LTD EBITDA is 17.26 B INR, and current EBITDA margin is 19.48%. See more stats in IPCA LABORATORIES LTD financial statements.
Like other stocks, IPCALAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IPCA LABORATORIES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IPCA LABORATORIES LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IPCA LABORATORIES LTD stock shows the buy signal. See more of IPCA LABORATORIES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.